X

Blog

QualityStocksNewsBreaks – Nowigence Inc.’s Pluaris Supporting Collaboration in the Most Efficient, Effective Way Possible

Nowigence shines in knowledge management, a category Gartner Inc. forecasts will be one of the top five use case categories…

QualityStocks

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Expanding into Live Resin Vapes Segment to Capitalize on Growing Market

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) recently announced the rollout of Platinum Vape(TM) (“PV”) Live Resin in Michigan,…

QualityStocks

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Moving to Become One of the Largest Payments Facilitators on the Lightning Network

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning…

QualityStocks

QualityStocksNewsBreaks – FuelPositive Corporation’s (TSX.V: NHHH) (OTCQB: NHHHF) System Offering Independence from Widely Fluctuating Supply Chain

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is helping build robust and decentralized food systems through its green ammonia production solution. The…

QualityStocks

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Releases New Lightning Network Node in India, Leveraging Growth of Cryptocurrency Use in the Area

The global cryptocurrency market is expected to grow at a CAGR of 12.8%, to reach US $4.94 billion by 2030…

QualityStocks

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Webcast to Discuss 2021 Financial and Operating Results

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it will…

QualityStocks

The 2nd Annual Gene Therapy Summit To Share Insights On Safer Gene Therapy Programs

The 2nd Annual Gene Therapy Summit will take place June 7-9, 2022, in Boston, MA. With a focus on effectively…

QualityStocks

Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Proprietary CYB003 Set to Move Forward in First-in-Human Phase 1/2a Clinical Trial

Cybin has selected Clinilabs Drug Development Corporation as CRO for its Phase 1/2a clinical trial evaluating CYB003 for treating major…

QualityStocks

Kronos Advanced Technologies Inc. (KNOS) Venturing into Metaverse with Initial eCommerce Virtual Store

“Metaverse refers to digital worlds in which people will gather to work, play and hang out,” explains CNET article Kronos…

QualityStocks

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Demonstrating ‘Encouraging Promise in Treatment of GBM’

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical cancer drug developer, recently reported new advances in its rollout of a global clinical…

QualityStocks